These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34099948)

  • 1. A mathematical programming approach for equitable COVID-19 vaccine distribution in developing countries.
    Tavana M; Govindan K; Nasr AK; Heidary MS; Mina H
    Ann Oper Res; 2021 Jun; ():1-34. PubMed ID: 34099948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
    Rastegar M; Tavana M; Meraj A; Mina H
    Vaccine; 2021 Jan; 39(3):495-504. PubMed ID: 33342632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equitable and effective vaccine access considering vaccine hesitancy and capacity constraints.
    Sengul Orgut I; Freeman N; Lewis D; Parton J
    Omega; 2023 Oct; 120():102898. PubMed ID: 37275337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal planning of the COVID-19 vaccine supply chain.
    Georgiadis GP; Georgiadis MC
    Vaccine; 2021 Aug; 39(37):5302-5312. PubMed ID: 34373118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty.
    Shiri M; Ahmadizar F
    J Ambient Intell Humaniz Comput; 2022 Jun; ():1-25. PubMed ID: 35692508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.
    Buhat CAH; Lutero DSM; Olave YH; Quindala KM; Recreo MGP; Talabis DASJ; Torres MC; Tubay JM; Rabajante JF
    Appl Health Econ Health Policy; 2021 Sep; 19(5):699-708. PubMed ID: 34169485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing COVID-19 vaccine allocation considering the target population.
    Wen Z; Yue T; Chen W; Jiang G; Hu B
    Front Public Health; 2022; 10():1015133. PubMed ID: 36684954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms.
    Kamran MA; Kia R; Goodarzian F; Ghasemi P
    Socioecon Plann Sci; 2023 Feb; 85():101378. PubMed ID: 35966449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-echelon dynamic cold chain for managing vaccine distribution.
    Manupati VK; Schoenherr T; Subramanian N; Ramkumar M; Soni B; Panigrahi S
    Transp Res E Logist Transp Rev; 2021 Dec; 156():102542. PubMed ID: 34815731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equitable access to COVID-19 vaccines makes a life-saving difference to all countries.
    Ye Y; Zhang Q; Wei X; Cao Z; Yuan HY; Zeng DD
    Nat Hum Behav; 2022 Feb; 6(2):207-216. PubMed ID: 35102361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism design for a fair and equitable approach to global vaccine distribution: The case of COVID-19.
    Abedrabboh K; Al-Majid L; Al-Fagih Z; Al-Fagih L
    PLOS Glob Public Health; 2023; 3(12):e0001711. PubMed ID: 38153908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the COVID-19 cold chain vaccine distribution network with medical waste management: A robust optimization approach.
    Ensar Işık E; Topaloglu Yildiz S
    Expert Syst Appl; 2023 Nov; 229():120510. PubMed ID: 37251535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengthening the immunization supply chain: A time-to-supply based approach to cold chain network optimization & extension in Madhya Pradesh.
    Srivastava V; Ratna M; Ray A; Shukla S; Shrivastava V; Kothari N; Gupta A; Kukreja M; Jandu HS
    Vaccine; 2021 Oct; 39(45):6660-6670. PubMed ID: 34629207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation.
    Sheikh AB; Pal S; Javed N; Shekhar R
    Infect Dis Rep; 2021 May; 13(2):429-436. PubMed ID: 34069242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The origins of the vaccine cold chain and a glimpse of the future.
    Lloyd J; Cheyne J
    Vaccine; 2017 Apr; 35(17):2115-2120. PubMed ID: 28364918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine and the cold chain implications for global adoption.
    Das MK
    Indian J Public Health; 2021; 65(3):307-310. PubMed ID: 34558497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equitable and Effective Distribution of the COVID-19 Vaccines - A Scientific and Moral Obligation.
    Binagwaho A; Mathewos K; Davis S
    Int J Health Policy Manag; 2022 Feb; 11(2):100-102. PubMed ID: 33949818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supply chain planning of vaccine and pharmaceutical clusters under uncertainty: The case of COVID-19.
    Kochakkashani F; Kayvanfar V; Haji A
    Socioecon Plann Sci; 2023 Jun; 87():101602. PubMed ID: 37255585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.